The effect of gabapantin in the controling pain after laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104132080N6

Enrollment

Registered

2011-07-22

Start date

2010-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colesystectomy laparascopy. Cholelithiasis

Interventions

Intervention 1: 300 mg of gabapantin 1 hour before operation. Intervention 2: placebo 1 hour before operation.

Prevention

Placebo

300 mg of gabapantin 1 hour before operation.

placebo 1 hour before operation.

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age group of 20-60. Exclusion criteria: history of using analgesic and narcotic prior to the surgery; history of chronic lung and heart diseases; history of using Corticostroid; history of moving disorders; history of smoking; patient who use Gabapantin; history of sensitivity to Gabapantine.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 2 hours. Method of measurement: VAS and check list and physical examination.	—

Secondary

Measure	Time frame
Tremur. Timepoint: each 2 hours. Method of measurement: check list and physical examination.;Nausea and vomitting. Timepoint: each 2 hours. Method of measurement: check list physical examination.;Confusion. Timepoint: each 2 hours. Method of measurement: check list and physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.afsaneh norouzi

Arak university of medical sciences

norouzi.a@arakmu.ac.ir+98 86 1222 4790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026